Fulgent Genetics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Fulgent Genetics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q3 2024.
  • Fulgent Genetics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$14.6M, a 11.8% decline year-over-year.
  • Fulgent Genetics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$165M, a 160% decline year-over-year.
  • Fulgent Genetics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$168M, a 217% decline from 2022.
  • Fulgent Genetics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $143M, a 71.7% decline from 2021.
  • Fulgent Genetics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $507M, a 137% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$165M -$14.6M -$1.54M -11.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$163M -$8.71M +$2.52M +22.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$166M -$13.5M +$1.88M +12.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 -$168M -$128M -$104M -438% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$63.5M -$13.1M -$14.8M -862% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$48.7M -$11.2M -$22.8M -197% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$25.9M -$15.3M -$169M -110% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $143M -$23.8M -$128M -123% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 $272M $1.72M -$121M -98.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $392M $11.5M -$68.3M -85.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $461M $154M -$46.7M -23.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $507M $104M -$62M -37.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $569M $123M +$75.9M +163% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-28
Q2 2021 $493M $79.8M +$76.5M +2303% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-28
Q1 2021 $417M $201M +$203M Jan 1, 2021 Mar 31, 2021 10-K 2023-02-28
Q4 2020 $214M $166M +$167M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 $47.7M $46.6M +$45.2M +3090% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-28
Q2 2020 $2.53M $3.32M +$2.99M +903% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-28
Q1 2020 -$459K -$1.96M -$48K -2.52% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-28
Q4 2019 -$411K -$296K +$1.76M +85.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-08
Q3 2019 -$2.17M $1.46M +$2.06M Jul 1, 2019 Sep 30, 2019 10-K 2021-03-08
Q2 2019 -$4.23M $331K +$1.38M Apr 1, 2019 Jun 30, 2019 10-K 2021-03-08
Q1 2019 -$5.61M -$1.91M +$2K +0.11% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-08
Q4 2018 -$5.61M -$2.05M -$429K -26.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$5.18M -$595K +$498K +45.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-13
Q2 2018 -$5.68M -$1.05M -$1.02M -4096% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-13
Q1 2018 -$4.65M -$1.91M -$2.14M -923% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-13
Q4 2017 -$2.51M -$1.62M -$2.44M -300% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$73K -$1.09M +$14K +1.27% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-22
Q2 2017 -$87K -$25K +$4.47M +99.4% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-22
Q1 2017 -$4.55M $232K +$834K Jan 1, 2017 Mar 31, 2017 10-K 2019-03-22
Q4 2016 -$5.39M $813K +$8.15M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-20
Q3 2016 -$13.5M -$1.11M -$2.29M -194% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-20
Q2 2016 -$11.3M -$4.49M -$5.24M -701% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-20
Q1 2016 -$6.01M -$602K -$1.03M -242% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-20
Q4 2015 -$4.99M -$7.34M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 $1.18M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-17
Q2 2015 $747K Apr 1, 2015 Jun 30, 2015 10-K 2017-03-17
Q1 2015 $425K Jan 1, 2015 Mar 31, 2015 10-K 2017-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.